EG21200A - Process for preparing organometallic addition to ketones - Google Patents

Process for preparing organometallic addition to ketones

Info

Publication number
EG21200A
EG21200A EG73196A EG73196A EG21200A EG 21200 A EG21200 A EG 21200A EG 73196 A EG73196 A EG 73196A EG 73196 A EG73196 A EG 73196A EG 21200 A EG21200 A EG 21200A
Authority
EG
Egypt
Prior art keywords
ketones
organometallic addition
preparing organometallic
preparing
addition
Prior art date
Application number
EG73196A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10778850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG21200(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of EG21200A publication Critical patent/EG21200A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EG73196A 1995-08-05 1996-08-04 Process for preparing organometallic addition to ketones EG21200A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516121.2A GB9516121D0 (en) 1995-08-05 1995-08-05 Organometallic addition to ketones

Publications (1)

Publication Number Publication Date
EG21200A true EG21200A (en) 2001-01-31

Family

ID=10778850

Family Applications (1)

Application Number Title Priority Date Filing Date
EG73196A EG21200A (en) 1995-08-05 1996-08-04 Process for preparing organometallic addition to ketones

Country Status (32)

Country Link
US (2) US6586594B1 (ru)
EP (1) EP0871625B1 (ru)
JP (3) JP3211965B2 (ru)
KR (1) KR100269048B1 (ru)
CN (1) CN1076019C (ru)
AR (1) AR003472A1 (ru)
AT (1) ATE256679T1 (ru)
AU (1) AU703337B2 (ru)
BR (1) BR9609960A (ru)
CA (1) CA2228655C (ru)
CZ (1) CZ296975B6 (ru)
DE (1) DE69631160T2 (ru)
DK (1) DK0871625T3 (ru)
EG (1) EG21200A (ru)
ES (1) ES2210382T3 (ru)
GB (1) GB9516121D0 (ru)
HK (1) HK1014944A1 (ru)
HU (1) HU224339B1 (ru)
IL (2) IL122462A (ru)
IN (1) IN190817B (ru)
MX (1) MX9801025A (ru)
MY (1) MY123062A (ru)
NO (1) NO314938B1 (ru)
NZ (1) NZ315651A (ru)
PE (1) PE16897A1 (ru)
PL (1) PL187227B1 (ru)
PT (1) PT871625E (ru)
RU (1) RU2156760C2 (ru)
TR (1) TR199800170T1 (ru)
TW (1) TW442480B (ru)
WO (1) WO1997006160A1 (ru)
ZA (1) ZA966587B (ru)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
CN1678321A (zh) * 2002-07-29 2005-10-05 里格尔药品股份有限公司 用2,4－嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法
US7122542B2 (en) * 2003-07-30 2006-10-17 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
JP2008511659A (ja) * 2004-09-01 2008-04-17 ライジェル ファーマシューティカルズ， インコーポレイテッド ２，４−ピリミジンジアミン化合物の合成
DK1814878T3 (da) * 2004-11-24 2012-05-07 Rigel Pharmaceuticals Inc Spiro-2, 4-pyrimidindiamin-forbindelser og anvendelser deraf
CA2590687C (en) * 2004-12-14 2013-09-10 Dr. Reddy's Laboratories Ltd. Process for preparing voriconazole
US20060270694A1 (en) * 2005-05-03 2006-11-30 Rigel Pharmaceuticals, Inc. JAK kinase inhibitors and their uses
EP2024344A2 (en) 2006-02-01 2009-02-18 Medichem, S.A. Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
CN1919846B (zh) * 2006-09-14 2013-01-02 大道隆达（北京）医药科技发展有限公司 伏立康唑及其药用盐、中间体的一种新定向合成制备方法
KR100889937B1 (ko) * 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
GB2452049A (en) * 2007-08-21 2009-02-25 Alpharma Aps Process for the preparation of voriconazole
WO2009084029A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
WO2010095145A1 (en) * 2009-02-17 2010-08-26 Glenmark Generics Limited Process for the preparation of voriconazole
KR101109215B1 (ko) 2009-06-17 2012-01-30 보령제약 주식회사 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법
US8288394B2 (en) * 2009-12-30 2012-10-16 Medichem, S.A. 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative
KR100971371B1 (ko) 2010-02-04 2010-07-20 동국제약 주식회사 신규한 중간체를 이용한 보리코나졸의 제조방법
EP2545039A1 (en) 2010-03-10 2013-01-16 Synthon BV A process for making voriconazole
CN102344441B (zh) * 2010-07-25 2015-05-06 浙江华海药业股份有限公司 一种制备伏立康唑中间体的工艺改进方法
CN101914091B (zh) * 2010-07-25 2015-05-27 浙江华海药业股份有限公司 一种制备伏立康唑中间体的方法
CA2827379A1 (en) * 2011-02-21 2012-08-30 Ranbaxy Laboratories Limited An improved process for the preparation of voriconazole and intermediates thereof
KR101731155B1 (ko) 2011-06-15 2017-04-27 신톤 비.브이. 안정화된 보리코나졸 조성물
CN102516233B (zh) * 2011-12-09 2014-04-09 北京联本医药化学技术有限公司 生产伏立康唑的方法
GR1007802B (el) * 2012-01-31 2013-01-18 Φαρματεν Αβεε, Μεθοδος για την παρασκευη παραγωγου της βρωμοπυρινιδινης
US9388167B2 (en) * 2012-10-15 2016-07-12 Pfizer Ireland Pharmaceuticals Process for the preparation of voriconazole and analogues thereof
KR101435741B1 (ko) 2013-01-17 2014-08-29 (주) 에프엔지리서치 신규한 보리코나졸 중간체 및 이를 이용한 보리코나졸의 제조 방법
CN105503834B (zh) * 2015-12-23 2021-03-05 浙江华海药业股份有限公司 一种伏立康唑中间体的合成方法
CN106432198B (zh) 2016-09-08 2022-10-21 浙江华海药业股份有限公司 一种制备伏立康唑拆分中间体的方法
CN106632267B (zh) * 2016-11-09 2019-02-22 中国科学院成都生物研究所 一种伏立康唑的合成方法
CN108276310A (zh) * 2017-01-06 2018-07-13 常州齐晖药业有限公司 一种伏立康唑拆分剂(r)-10-樟脑磺酸的回收方法
CN108586433A (zh) * 2017-07-21 2018-09-28 齐鲁工业大学 具有抗菌活性的伏立康唑盐酸盐
CN109705102A (zh) * 2019-02-19 2019-05-03 浙江华海立诚药业有限公司 伏立康唑及其中间体的制备方法
CN110305113A (zh) * 2019-07-05 2019-10-08 镇江市第四人民医院（镇江市妇幼保健院） 一种伏立康唑杂质b的合成方法
CN112442017A (zh) * 2019-08-29 2021-03-05 珠海润都制药股份有限公司 一种采用微通道反应器制备伏立康唑消旋体的方法
CN110724130A (zh) * 2019-11-29 2020-01-24 怀化学院 伏立康唑及其中间体的合成方法
CN111440152B (zh) * 2020-05-18 2022-09-27 浙江诚意药业股份有限公司 一种伏立康唑的制备方法
CN112079819B (zh) * 2020-09-24 2022-06-17 南京易亨制药有限公司 一种改进的伏立康唑消旋体制备方法
CN112645935A (zh) * 2020-12-15 2021-04-13 植恩生物技术股份有限公司 伏立康唑关键中间体的制备方法
CN115724829A (zh) * 2022-12-23 2023-03-03 天津力生制药股份有限公司 一种分离真菌药物中间体杂质的液相色谱制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
EP0665225B1 (en) * 1994-02-01 1996-11-27 Ube Industries, Ltd. 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same

Also Published As

Publication number Publication date
NO980441D0 (no) 1998-02-02
AU6740396A (en) 1997-03-05
NO980441L (no) 1998-03-26
HK1014944A1 (en) 1999-10-08
MX9801025A (es) 1998-04-30
JPH10510549A (ja) 1998-10-13
DK0871625T3 (da) 2004-03-29
AR003472A1 (es) 1998-08-05
PT871625E (pt) 2004-04-30
PL324922A1 (en) 1998-06-22
US20030181720A1 (en) 2003-09-25
IL122462A (en) 2001-10-31
JP3224532B2 (ja) 2001-10-29
CN1195346A (zh) 1998-10-07
GB9516121D0 (en) 1995-10-04
CA2228655C (en) 2003-09-09
EP0871625A1 (en) 1998-10-21
ES2210382T3 (es) 2004-07-01
NO314938B1 (no) 2003-06-16
ZA966587B (en) 1998-02-02
IN190817B (ru) 2003-08-23
HU224339B1 (hu) 2005-08-29
CZ296975B6 (cs) 2006-08-16
RU2156760C2 (ru) 2000-09-27
US6586594B1 (en) 2003-07-01
TW442480B (en) 2001-06-23
DE69631160D1 (de) 2004-01-29
DE69631160T2 (de) 2004-07-08
AU703337B2 (en) 1999-03-25
BR9609960A (pt) 1999-02-02
NZ315651A (en) 1999-03-29
KR100269048B1 (ko) 2000-10-16
KR19990036174A (ko) 1999-05-25
CZ32798A3 (cs) 1999-03-17
PL187227B1 (pl) 2004-06-30
EP0871625B1 (en) 2003-12-17
CN1076019C (zh) 2001-12-12
JP2001026583A (ja) 2001-01-30
WO1997006160A1 (en) 1997-02-20
IL122462A0 (en) 1998-06-15
CA2228655A1 (en) 1997-02-20
MY123062A (en) 2006-05-31
IL131521A0 (en) 2001-01-28
HUP9802766A2 (hu) 1999-02-01
ATE256679T1 (de) 2004-01-15
TR199800170T1 (xx) 1998-06-22
HUP9802766A3 (en) 2000-03-28
US6946555B2 (en) 2005-09-20
IL131521A (en) 2001-08-08
JP3211965B2 (ja) 2001-09-25
PE16897A1 (es) 1997-05-21
JP2001354670A (ja) 2001-12-25

Similar Documents

Publication Publication Date Title
EG21200A (en) Process for preparing organometallic addition to ketones
AU1988295A (en) Improved process for preparing water soluble polyaluminosilicates
CZ252597A3 (cs) Způsob výroby azacyklohexapeptidů
HUP9900318A3 (en) Process for preparing 4-aryl-piperidine derivatives
HK1012636A1 (en) Process for preparing cyclic polysiloxanes
IL119402A0 (en) Process for preparing nicotinamide
SG52595A1 (en) Process for preparing powdered seasonings
ZA96982B (en) Process for preparing an organoaluminoxy product
GB2263113B (en) Process for producing trialkoxysilane
HK1017360A1 (en) Process for preparing n-phosphonomethylglycine
IL118992A (en) Process for preparing norbenzomorphan derivatives
HUP9602579A2 (en) Process for preparing of food
EP0463522A3 (en) Method for preparing carboxy functional silicones
EP0742221A3 (en) Process for the production of trimethyl aluminum
HUP9602960A2 (en) Process for producing alkylcarbazates
HUP9903571A3 (en) Process for preparing dioxoazabicyclohexan-derivatives
HUP9602988A3 (en) Process for producing 2-chloracrylnitril
GR3030254T3 (en) Process for preparing substituted aminotriazolinones
EP0751112A3 (de) Verfahren zur Herstellung von Arylidensubstituierten Alkylcycloalkanonen
GB9613005D0 (en) Process for preparing 4-tert-butyloxycarbonyl-(s)-piperazine-2-tert-butylcarboxamide
HK1017587A1 (en) Process for preparing fermented seasonings
EP0751111A3 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
EP0771892A4 (en) METHOD FOR PRODUCING DECORATIVE SILICONS
HU9503733D0 (en) Process for producing veratrumaldehyde
LT95056A (en) Process for preparing cake